The U.S. pharmacy market is projected to reach USD 708.9 billion by 2030, with a compound annual growth rate (CAGR) of 3.67% from 2023 to 2030, according to a new report by Grand View Research, Inc. This growth is driven by several critical factors, such as the increasing prevalence of chronic diseases, the aging population, and expanding healthcare coverage. The expansion of healthcare coverage, in particular, is expected to provide more individuals with access to essential medications, which in turn will drive demand for both healthcare services and pharmaceutical products.

As chronic diseases like heart disease, diabetes, and respiratory disorders continue to rise, the demand for long-term treatments and medications is also escalating. At the same time, the aging population in the U.S., with a significant proportion of older adults requiring regular medication, further strengthens this trend. This demographic shift, coupled with increasing access to healthcare, is poised to provide the U.S. pharmacy market with sustained growth. Read more @ https://www.grandviewresearch.....com/industry-analysi